NF-κB and the innate immune response

Current Opinion in Immunology

Volumn 12, Issue 1, 2000, Pages 52-58

  Hatada, Eunice N ^a   Krappmann, Daniel ^a   Scheidereit, Claus ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; PROTEIN INHIBITOR; UBIQUITIN; I KAPPA B KINASE; PROTEIN SERINE THREONINE KINASE;

BIOCHEMISTRY; CELL SURVIVAL; DEVELOPMENT; GENETICS; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ENZYME ACTIVATION; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; VIRULENCE;

ENZYME ACTIVATION; I-KAPPA B KINASE; IMMUNITY, NATURAL; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; VIRULENCE;

EID: 0033621709     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00050-3     Document Type: Review

References (46)

1. Baeuerle P.A., Baltimore D. NF-κB: ten years after. Cell. 87:1996;13-20.
2. Baldwin A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 14:1996;649-681.
3. Gerondakis S., Grumont R., Rourke I., Grossmann M. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation. Curr Opin Immunol. 10:1998;353-359.
4. Attar R.M., Caamano J., Carrasco D., Iotsova V., Ishikawa H., Ryseck R.P., Weih F., Bravo R. Genetic approaches to study Rel/NF-κB/IκB function in mice. Semin Cancer Biol. 8:1997;93-101.
5. Foo S.Y., Nolan G.P. NF-κB to the rescue - RELs, apoptosis and cellular transformation. Trends Genet. 15:1999;229-235.
6. Stancovski I., Baltimore D. NF-κB activation: the IκB kinase revealed? Cell. 91:1997;299-302.
7. ••], revealed that IKKα is critical for skin and skeletal development.
8. ••].
9. ••].
10. Seitz C.S., Lin Q., Deng H., Khavari P.A. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc Natl Acad Sci USA. 95:1998;2307-2312.
11. ••], that IKKβ is needed for cytokine-induced kinase activity of the IKK complex and subsequent NF-κB activation.
12. ••].
13. ••].
14. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240. This elegant work identified NEMO/IKKγ as an essential component of the IKK complex by genetic complementation of a mutant cell line unresponsive to NF-κB activating stimuli.
15. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300.
16. Mercurio F., Murray B.W., Shevchenko A., Bennett B.L., Young D.B., Li J.W., Pascual G., Motiwala A., Zhu H., Mann M., Manning A.M. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol. 19:1999;1526-1538.
17. Cohen L., Henzel W.J., Baeuerle P.A. IKAP is a scaffold protein of the IκB kinase complex. Nature. 395:1998;292-296.
18. Shimada T., Kawai T., Takeda K., Matsumoto M., Inoue J-I., Tatsumi Y., Kanamaru A., Akira S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Intl Immunol. 11:1999;1357-1362.
19. Bender K., Gottlicher M., Whiteside S., Rahmsdorf H.J., Herrlich P. Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J. 17:1998;5170-5181.
20. Li N., Karin M. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc Natl Acad Sci USA. 95:1998;13012-13017.
21. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity. 9:1998;143-150.
22. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
23. Kanakaraj P., Schafer P.H., Cavender D.E., Wu Y., Ngo K., Grealish P.F., Wadsworth S.A., Peterson P.A., Siekierka J.J., Harris C.A., Fung-Leung W.P. Interleukin (IL)-1 receptor-associated kinase (IRAK) requirement for optimal induction of multiple IL-1 signaling pathways and IL-6 production. J Exp Med. 187:1998;2073-2079.
24. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C., Ho A., Morony S., Capparelli C., Van G., Kaufman S.et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1999;1015-1024.
25. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., Leonardi A., Tran T., Boyce B.F., Siebenlist U. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:1997;3482-3496.
26. Delhase M., Hayakawa M., Chen Y., Karin M. Positive and negative regulation of IκB kinase activity through IKKβ subunit phosphorylation. Science. 284:1999;309-313. This comprehensive IKK structure/function analysis proposes a model for activation and inhibition of IKKβ by phosphorylation of the T loop and the carboxy-terminal serine cluster, respectively.
27. Lee F.S., Peters R.T., Dang L.C., Maniatis T. MEKK1 activates both IκB kinase α and IκB kinase β Proc Natl Acad Sci USA. 95:1998;9319-9324.
28. Nemoto S., DiDonato J.A., Lin A. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase. Mol Cell Biol. 18:1998;7336-7343.
29. Zhao Q., Lee F.S. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IκB kinase-β J Biol Chem. 274:1999;8355-8358.
30. Ling L., Cao Z., Goeddel D.V. NF-κB-inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc Natl Acad Sci USA. 95:1998;3792-3797.
31. Karin M., Delhase M. JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? Proc Natl Acad Sci USA. 95:1998;9067-9069.
32. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., Matsumoto K. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 398:1999;252-256.
33. Lin X., Cunningham E.T. Jr., Mu Y., Geleziunas R., Greene W.C. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity. 10:1999;271-280.
34. Kopp E., Medzhitov R., Carothers J., Xiao C., Douglas I., Janeway C.A., Ghosh S. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13:1999;2059-2071.
35. •] provide the first insight into how IκBs are targeted for ubiquitination. They identify β-TrCP, a mammalian homolog of Drosophila Slimb, as a component of the IκB ubiquitin ligase.
36. •].
37. •].
38. Fuchs S.Y., Chen A., Xiong Y., Pan Z-Q., Ronai Z. HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and, Cullin1 and targets the phosphorylation-dependent degradation of IκB and β-catenin. Oncogene. 18:1999;2039-2046.
39. Tan P., Fuchs S.Y., Chen A., Wu K., Gomez C., Ronai Z., Pan Z.Q. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of IκBα Mol Cell. 3:1999;527-533.
40. Maniatis T. A ubiquitin ligase complex essential for the NF-κB, Wnt/Wingless and Hedgehog signaling pathways. Genes Dev. 13:1999;505-510.
41. Laney J.D., Hochstrasser M. Substrate targetting in the ubiquitin system. Cell. 97:1999;427-430.
42. Heissmeyer V., Krappmann D., Wulczyn F.G., Scheidereit C. NF-κB p105 is a target of IκB kinases and controls signal-induction of Bcl-3-p50 complexes. EMBO J. 18:1999;4766-4778.
43. Belich M.P., Salmeron A., Johnston L.H., Ley S.C. TPL-2 kinase regulates the proteolysis of the NF-κB-inhibitory protein NF-κB1 p105. Nature. 397:1999;363-368.
44. Pomeranz J.L., Baltimore D. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18:1999;6694-6704.
45. Nguyen L.T., Duncan G.S., Mirtsos C., Ng M., Speiser D.E., Shahinian A., Marino M., Mak T.W., Ohashi P.S., Yeh W-C. TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity. 11:1999;379-389.
46. Yeh W.C., Shahinian A., Speiser D., Kraunus J., Billia F., Wakeham A., de la Pompa J.L., Ferrick D., Hum B., Iscove N.et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity. 7:1999;715-725.